APAC mHealth Market

APAC mHealth Market Size (2024 to 2032)

The size of the Asia-Pacific mHealth market is estimated to be worth USD 20.02 Billion in 2024 and USD 62.00 Billion by 2032, at a CAGR of 15.17% during the forecast period. Asia Pacific is more likely to witness the most significant market growth in the forecast period owing to its health care and research developments.

The increasing adoption of smartphones and rising internet penetration are primarily driving the mobile health market in the Asia-Pacific region. As per the report in 2019, an estimated 2.8 billion people in the Asia Pacific are using mobile phones. The development of affordable and high-quality smartphones improves the communication between doctors and patients for medical treatment. In addition, many software companies are focusing on developing software for smart devices used by the population for healthcare treatment. The growing awareness regarding personal health and fitness across the population of the APAC region is another notable attribute contributing to the mHealth market growth in the Asia-Pacific region. In addition, the growing number of people suffering from obesity is expected to accelerate the usage of mobile health in APAC and contribute to regional market growth.

Furthermore, the growing usage of remote patient monitoring devices and the increasing number of advancements in healthcare technologies are favoring the mHealth market growth in APAC. The growing geriatric population in the APAC region is fuelling the usage of remote patient monitoring devices to increase their life span, which is supporting the mobile health market in this region. The sensor used in remote patient monitoring devices is connected to the mobile device through Bluetooth to transfer the data from the devices to the mobile phone. The data is sent to the healthcare provider for further treatment. Mainly used remote patient monitoring devices are glucose meters, blood pressure devices, oxygen monitoring and others.

On the other hand, poor awareness among the older population of APAC regarding the benefits of mHealth is one of the significant restraints to the mHealth market growth in the Asia-Pacific region. In addition, extended time for the approval of the applications from the regulatory bodies, lack of data privacy, and inaccurate data from the monitoring devices are further impeding the market growth in this region.

This research report on the Asia Pacific mHealth Market has been segmented and sub-segmented into the following categories.

By Connected Devices

• Glucose Meter
• Pulse Oximeter
• Blood Pressure Monitor

The blood pressure monitor segment is predicted to capture the major share of the mobile health market of the APAC region during the forecast period owing to the rising patient population.

By Services: 

• Fitness and Wellness
• Remote Monitoring Consultation
• Prevention

The remote monitoring segment is predicted to witness the fastest CAGR during the forecast period in the APAC market.

By Application: 

• Women's Health
• Weight Loss
• Chronic Care Management
• Health and Fitness
• Medication
• Personal Health Record

The fitness and health segment is expected to lead the APAC mHealth market during the forecast period.

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, the APAC mHealth market had a considerable share of the global market in 2022 and is predicted to grow at the fastest CAGR during the forecast period owing to the increasing adoption of digital technology in the healthcare sector. China accounted for the leading share of the APAC market in 2022 and the same trend is predicted to continue during the forecast period owing to the presence of numerous market participants and rising usage of mobile health applications. The availability of technological developments such as 5G in China is favoring the Chinese mHealth market. During the covid-19 pandemic, increased usage of telehealth services has been noticed in China to reduce the spread of the virus among the population in China.

During the forecast period, the Japan mHealth market is predicted to occupy a considerable share of the APAC market. The growth of the Japanese market is majorly driven by the growing patient population suffering from chronic diseases such as cancer, heart-related disease, and diabetes. People are increasing their healthcare expenditure by using home healthcare devices to support quality of life. An estimated 60% of deaths in Japan are due to chronic diseases. mHealth applications in Japan contain an educational video that helps to improve the user's health literacy and reduce the risk of diseases in their daily life. The government has given several guidelines for making videos related to spreading awareness in the population about different diseases.

The Indian mHealth market is anticipated to register a noteworthy CAGR during the forecast period owing to the growing number of initiatives of the Indian government in favor of mobile health. India's government has been more involved in the demand for mHealth among the population. Information & Communications technology plays a significant role in developing the healthcare sector in India. Advanced technologies such as IoT, machine learning, and artificial intelligence are used in healthcare applications for accurate results. Some of the mHealth applications in India are the vaccine tracker app, India Fights Dengue app, national health portal, and dengue app—increasing awareness programs about the application among the population demand market growth in this country.

KEY MARKET PLAYERS

Samsung Electronics Co., Ltd., Huawei Technologies Co., Ltd., Google LLC, Fitbit, Inc. and Apple Inc. are some of the notable players in the APAC mHealth market.